Amniotic membrane transplantation

By Next Biosciences

30 October 2015

Lee, Shwu-Huey; Tseng, Scheffer C G
American Journal of Ophthalmology; Mar 1997; 123, 3; ProQuest Central pg 303

  • Purpose: To determine whether preserved human amniotic membrane can be used as an alternative substrate for treating persistent corneal epithelial defects with sterile ulceration.
  • Methods: Amniotic membrane transplantation was performed in 11 eyes of 11 consecutive patients with corneal ulcers of different causes that had persisted for a mean ± SD of 17.5 ±13.9 weeks.
  • Results: Ten patients healed in 3.9 ± 2.3 weeks (P < .01) without recurrence for 9.0 ± 5.9 months. One patient failed to heal because of pre-existing corneal perforation pursuant to severe rheumatoid arthritis.
  • Conclusion: Amniotic membrane transplantation may be considered an alternative method for treating persistent epithelial defects and sterile ulceration that are refractory to conventional treatment and before considering treatment by conjunctival flaps or tarsorrhaphy.